Synthesis and Reactions of Polyazamacrolides
J . Org. Chem., Vol. 66, No. 4, 2001 1093
δ 0.06 (s, 6Η), 0.90 (s, 9H), 1.17-1.25 (m, 2H), 1.34 (s, 6H),
1.45 (s, 9H), 1.70 (qn, J ) 7.6 Hz, 2H), 1.75-1.82 (m, 2H),
1.97 (q, J ) 7.2 Hz, 2H), 2.06 (q, J ) 7.2 Hz, 2H), 2.36 (t, J )
7.2 Hz, 2H), 3.34 (t, J ) 6.8 Hz, 2H), 3.62 (t, J ) 6.8 Hz, 2H),
5.12 (s, 2H), 5.29-5.36 (m, 1H), 5.35-5.42 (m, 1H), 7.30-7.40
(m, 5H); 13C NMR (100 MHz, CDCl3) δ -5.3, 18.3, 24.6, 24.9,
26.0, 26.5, 27.4, 28.2, 28.6, 33.7, 40.1, 47.1, 57.9, 62.6, 66.1,
79.0, 128.2, 128.5, 131.0, 136.1, 155.3, 173.5; IR 1740, 1698,
1680 cm-1; MS (FAB) m/z (rel int) 462 [20, (MH-Boc)+], 220
(37), 216 (100), 176 (29); HRMS FAB calcd for C27H48NO3Si
[MH-Boc]+ 462.3403, found 462.3402.
6H), 1.90-2.00 (m, 6H), 2.00-2.10 (m, 6H), 2.30 (t, J ) 7.6
Hz, 4H), 2.36 (t, J ) 7.6 Hz, 2H), 3.33 (t, J ) 6.6 Hz, 2H), 3.46
(t, J ) 6.6 Hz, 4H), 3.62 (t, J ) 6.6 Hz, 2H), 4.09 (t, J ) 6.6
Hz, 4H), 5.11 (s, 2H), 5.28-5.42 (m, 6H), 7.32-7.38 (m, 5H);
13C NMR (100 MHz, CDCl3) δ -5.3, 18.3, 24.5, 24.8, 26.0, 26.6,
27.4, 27.4, 27.4, 28.2, 28.5, 28.6, 33.6, 33.7, 40.1, 43.5, 47.1,
57.8, 58.0, 62.6, 63.4, 66.1, 79.0, 79.5, 128.2, 128.5, 128.5, 128.6,
130.8, 131.0, 136.0, 155.1, 155.3, 173.4; IR 1740, 1700, 1682
cm-1; MS (FAB) m/z (rel int) 1141 [3, (MH-Boc)+], 1085 [5, (M-
Boc-C4H9)+], 613 (10), 216 (100); HRMS FAB calcd for
C
65H114N3O11Si [MH-Boc]+ 1140.8223, found 1140.8225.
Ben zyl (5Z)-N-(ter t-Bu toxyca r bon yl)-N-(2-h yd r oxyeth -
yl)-10-a m in o-10-m eth ylu n d ec-5-en oa te (32). Operating in
a manner analogous to that employed for the preparation of
20, starting from 31 (114 mg, 0.20 mmol) alcohol 32 was
obtained (90 mg, quantitative) after chromatographic purifica-
tion (50:50 hexanes-Et2O): 1H NMR (400 MHz, CDCl3) δ
1.20-1.30 (m, 2H), 1.32 (s, 6H), 1.47 (s, 9H), 1.71 (qn, J ) 7.6
Hz, 2H), 1.74-1.80 (m, 2H), 1.99 (q, J ) 7.2 Hz, 2H), 2.06 (q,
J ) 7.2 Hz, 2H), 2.36 (t, J ) 6.8 Hz, 2H), 3.47 (t, J ) 5.6 Hz,
2H), 3.68 (t, J ) 5.6 Hz, 2H), 5.12 (s, 2H), 5.33 (td, J ) 10.8
and 6.8 Hz, 1H), 5.39 (td, J ) 10.8 and 6.8 Hz, 1H), 7.30-7.40
(m, 5H); 13C NMR (100 MHz, CDCl3) δ 24.4, 24.8, 26.5, 27.3,
28.5, 33.7, 40.4, 47.4, 58.1, 64.3, 66.1, 80.3, 128.2, 128.5, 128.7,
130.7, 136.0, 157.5, 173.4.
Ben zyl (5Z,5′Z,5′′Z)-N,N′,N′′-Tr is(ter t-bu toxyca r bon yl)-
N-{N′-[N′′-(2-h yd r oxyeth yl)-10-a m in o-10-m eth ylu n d ec-5-
en oyloxyet h yl]-10-a m in o-10-m et h ylu n d ec-5-en oyloxy-
eth yl}-10-am in o-10-m eth ylu n dec-5-en oate (36). Proceeding
from ester 35 (50 mg, 0.05 mmol) in the manner described for
for the preparation of 19, alcohol 36 (38 mg, 84%) was isolated
after chromatographic purification (Et2O): 1H NMR (400 MHz,
CDCl3) δ 1.16-1.30 (m, 6H), 1.33 (s, 12H), 1.34 (s, 6H), 1.45
(s, 9H), 1.46 (s, 9H), 1.48 (s, 9H), 1.64-1.72 (m, 6H), 1.75-
1.83 (m, 6H), 1.99 (q, J ) 6.8 Hz, 6H), 2.00-2.08 (m, 6H), 2.30
(t, J ) 7.6 Hz, 2H), 2.31 (t, J ) 7.6 Hz, 2H), 2.32 (t, J ) 7.6
Hz, 2H), 3.09 (br s, 1H), 3.47 (t, J ) 6.4 Hz, 4H), 3.48 (t, J )
5.6 Hz, 2H), 3.69 (q, J ) 5.6 Hz, 2H), 4.10 (t, J ) 6.4 Hz, 4H),
5.12 (s, 2H), 5.28-5.43 (m, 6H), 7.35-7.40 (m, 5H); 13C NMR
(100 MHz, CDCl3) δ 24.4, 24.5, 24.8, 24.8, 24.8, 26.5, 26.5, 27.3,
28.2, 28.4, 28.5, 33.6, 33.7, 40.1, 40.4, 43.5, 47.4, 58.0, 58.1,
63.4, 64.2, 66.1, 79.6, 80.2, 128.1, 128.5, 128.6, 128.7, 130.7,
130.8, 130.8, 136.0, 155.1, 157.4, 173.4.
(5Z,5′Z,5′′Z)-N,N′,N′′-Tr is(ter t-bu toxyca r bon yl)-N-{N′-
[N′′-(2-h yd r oxyeth yl)-10-a m in o-10-m eth ylu n d ec-5-en oyl-
oxyet h yl]-10-a m in o-10-m et h ylu n d ec-5-en oyloxyet h yl}-
10-am in o-10-m eth ylu n dec-5-en oic Acid (37). Hydrogenolysis
of benzyl ester 36 (38 mg, 0.03 mmol) using the conditions
employed for the preparation of 18 furnished hydroxy acid 37
(30 mg, 79%): 1H NMR (400 MHz, CDCl3) δ 1.10-1.20 (m,
6H), 1.24-1.30 (m, 24H), 1.33 (s, 12H), 1.34 (s, 6H), 1.46 (s,
18H), 1.48 (s, 9H), 1.58-1.63 (m, 6H), 1.72-1.80 (m, 6H), 2.30
(t, J ) 7.6 Hz, 6H), 2.36 (br s, 1H), 3.47 (t, J ) 6.6 Hz, 4H),
3.48 (t, J ) 5.2 Hz, 2H), 3.70 (q, J ) 5.2 Hz, 2H), 4.10 (t, J )
6.6 Hz, 4H); 13C NMR (100 MHz, C6D6) δ 25.1, 25.2, 25.2, 25.6,
25.6, 28.6, 28.8, 28.9, 29.8, 29.9, 30.0, 30.0, 30.1, 30.2, 30.3,
30.7, 30.8, 34.7, 34.8, 41.1, 41.5, 44.3, 48.0, 58.5, 58.7, 64.1,
64.2, 79.7, 80.1, 155.5, 157.4, 173.4; MS (ESI) m/z (rel int) 1041
[45, (M-H)-], 941 [5, (M-H-Boc)-], 358 (44), 258 (100).
N,N′,N′′-Tr is(ter t-bu toxyca r bon yl)-5,5,19,19,33,33-h ex-
am eth yl-1,15,29-tr ioxa-4,18,32-tr iazacyclodotetr acon tan e-
14,28,42-tr ion e (38). Following the macrolactonization pro-
cedure described for the preparation of 24, starting from
hydroxy acid 37 (30 mg, 0.03 mmol), macrocycle 38 (20 mg,
69%) was obtained after chromatography (60:40 hexanes-
Et2O): 1H NMR (400 MHz, C6D6) δ 1.15-1.25 (m, 30H), 1.30
(s, 18H), 1.41 (s, 27H), 1.52-1.62 (m, 6H), 1.84-1.92 (m, 6H),
2.16 (t, J ) 7.6 Hz, 6H), 3.46 (t, J ) 6.4 Hz, 6H), 4.25 (t, J )
6.4 Hz, 6H); 13C NMR (100 MHz, C6D6) δ 25.2, 25.6, 28.6, 28.9,
29.8, 29.8, 30.2, 30.7, 34.8, 41.2, 44.3, 58.7, 64.1, 79.5, 155.4,
173.3; IR 1740, 1696 cm-1; MS (FAB) m/z (rel int) 925 [14,
(MH-Boc)+], 869 [35, (M-Boc-C4H9)+], 528 (54), 282 (100), 242
(60); HRMS FAB calcd for C52H99N3O10 [MH-Boc]+ 925.7330,
found 925.7332.
Ben zyl (5Z,5′Z)-N,N′-Bis(ter t-bu toxyca r bon yl)-N-{N′-
[2-(ter t-bu tyld im eth ylsilyloxy)eth yl]-10-a m in o-10-m eth -
ylu n d ec-5-en oyloxyet h yl}-10-a m in o-10-m et h ylu n d ec-5-
en oa te (33). The dimeric ester 33 was obtained from acid 30
(32 mg, 0.07 mmol), alcohol 32 (30 mg, 0.07 mmol), DMAP (4
mg, 0.03 mmol), and EDCI‚HCl (13 mg, 0.07 mmol) following
the procedure for the preparation of 19. Final chromatographic
purification (60:40 hexanes-Et2O) afforded the title ester (50
mg, 90%) as a colorless oil: 1H NMR (400 MHz, CDCl3) δ 0.06
(s, 6Η), 0.90 (s, 9H), 1.15-1.30 (m, 4H), 1.33 (s, 12H), 1.46 (s,
18H), 1.60-1.75 (m, 4H), 1.75-1.85 (m, 4H), 1.94-2.00 (m,
4H), 2.00-2.10 (m, 4H), 2.30 (t, J ) 7.6 Hz, 2H), 2.36 (t, J )
7.6 Hz, 2H), 3.34 (t, J ) 6.6 Hz, 2H), 3.46 (t, J ) 6.6 Hz, 2H),
3.62 (t, J ) 6.6 Hz, 2H), 4.10 (t, J ) 6.6 Hz, 2H), 5.12 (s, 2H),
5.30-5.40 (m, 4H), 7.27-7.40 (m, 5H); 13C NMR (100 MHz,
CDCl3) δ -5.3, 18.3, 24.6, 24.8, 26.0, 26.6, 26.6, 27.4, 27.5, 28.2,
28.5, 28.6, 33.7, 33.7, 40.1, 43.5, 47.2, 57.9, 58.0, 62.6, 63.4,
66.1, 79.0, 79.5, 128.2, 128.2, 128.5, 128.5, 128.6, 130.8, 131.0,
136.1, 155.1, 155.3, 173.5; IR 1740, 1700, 1682 cm-1; MS (FAB)
m/z (rel int) 801 [10, (MH-Boc)+], 745 [21, (M-Boc-C4H9)+], 515
(22), 459 (27), 216 (100), 162 (43); HRMS FAB calcd for
C
46H81N2O7Si [MH-Boc]+ 801.5813 found 801.5813.
Ben zyl (5Z,5′Z)-N,N′-Bis(ter t-bu toxyca r bon yl)-N-[N′-(2-
h yd r oxyeth yl)-10-a m in o-10-m eth ylu n d ec-5-en oyloxyeth -
yl]-10-a m in o-10-m eth ylu n d ec-5-en oa te (34). Proceeding
from 33 (76 mg, 0.08 mmol) in the manner described for for
the preparation of 20, alcohol 34 (50 mg, 76%) was obtained
after chromatographic purification (50:50 hexanes-Et2O): 1H
NMR (400 MHz, CDCl3) δ 1.17-1.30 (m, 4H), 1.33 (s, 12H),
1.46 (s, 9H), 1.48 (s, 9H), 1.65-1.72 (m, 4H), 1.74-1.81 (m,
4H), 1.95-2.02 (m, 4H), 2.00-2.10 (m, 4H), 2.31 (t, J ) 7.6
Hz, 2H), 2.36 (t, J ) 7.6 Hz, 2H), 3.09 (br s, 1H), 3.46 (t, J )
6.8 Hz, 2H), 3.48 (t, J ) 5.2 Hz, 2H), 3.69 (q, J ) 5.2 Hz, 2H),
4.10 (t, J ) 6.8 Hz, 2H), 5.12 (s, 2H), 5.28-5.42 (m, 4H), 7.30-
7.40 (m, 5H); 13C NMR (100 MHz, CDCl3) δ 24.4, 24.5, 24.8,
24.8, 26.5, 26.5, 27.3, 28.2, 28.4, 28.5, 33.6, 33.7, 40.1, 40.4,
43.5, 47.4, 58.0, 58.1, 63.4, 64.1, 66.0, 79.5, 80.2, 128.1, 128.5,
128.6, 128.7, 130.7, 130.8, 136.0, 155.1, 157.4, 173.4.
Ben zyl (5Z,5′Z,5′′Z)-N,N′,N′′-Tr is(ter t-bu toxyca r bon yl)-
N-(N′-{N′′-[2-(ter t-bu tyld im eth ylsilyloxy)eth yl]-10-a m in o-
10-m eth ylu n dec-5-en oyloxyeth yl}-10-am in o-10-m eth ylu n -
d e c -5-e n o y lo x y e t h y l)-10-a m in o -10-m e t h y lu n d e c -5-
en oa te (35). Following the procedure for the preparation of
ester 19, starting from acid 30 (30 mg, 0.06 mmol), alcohol 34
(50 mg, 0.06 mmol), DMAP (4 mg, 0.03 mmol), and EDCI‚HCl
(12 mg, 0.06 mmol), trimeric ester 35 (66 mg, 85%) was
obtained as a colorless oil after chromatographic purification
(60:40 hexanes-Et2O): 1H NMR (400 MHz, CDCl3) δ 0.06 (s,
6Η), 0.90 (s, 9H), 1.18-1.26 (m, 6H), 1.33 (s, 6H), 1.34 (s, 12H),
1.45 (s, 18H), 1.46 (s, 9H), 1.63-1.72 (m, 6H), 1.77-1.82 (m,
5,5,19,19,33,33-H exa m et h yl-1,15,29-t r ioxa -4,18,32-t r i-
a za cyclod otetr a con ta n e-14,28,42-tr ion e Tr is(d 3-tr iflu o-
r oa cetic) Sa lt (39). Lactame 38 (8 mg, 8 µmol) was dissolved
in trifluoroacetic acid-d4 (100 µL) and stirred at room temper-
ature for 15 min. Evaporation of excess acid in vacuo yielded
trifluoroacetic salt 39 (8 mg, quantitative): 1H NMR (400 MHz,
CDCl3) δ 1.20-1.40 (m, 30H), 1.54 (s, 18H), 1.50-1.70 (m,
12H), 2.35 (t, J ) 7.6 Hz, 6H), 3.25-3.35 (m, 6H), 4.30-4.40
(m, 6H); 13C NMR (100 MHz, CDCl3) δ 23.3, 23.4, 24.5, 25.5,
28.9, 29.0, 29.1, 29.5, 33.7, 39.6, 60.2, 89.3, 114.4 (q, J ) 285
Hz), 156.2 (q, J ) 41 Hz), 174.3; IR 1778, 1744, 1676, 1174
cm-1
.
Rea r r a n gem en t of Tr is(10-m eth yl)P AML 681. The O-
to-N acyl migration of polyazamacrolide 12 was monitored
using 1H NMR and HPLC-MS techniques in the same manner